🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kai He

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

ORCID: 0000-0002-4378-9297

Also affiliated with University of the Potomac

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors

Cancer Investigation(2025)10.1080/07357907.2025.2557004
Top 78%
0.104DataRank
Top 78%1 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +15 more

Papers

Driven by 16 papers — median percentile 11. Top paper: “Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer”.

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02674-w
N/A
0.571DataRank · unranked
44 citations

Daniel Spakowicz, Songzhu Zhao, Sandip H. Patel, Andrew Johns, Madison Grogan +11 more

Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9024
N/A
0.312DataRank · unranked
7 citations

David P. Carbone, Meredith McKean, Rama Balaraman, Satish Shah, Edward Arrowsmith +11 more

Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors

Cancer Investigation(2025)10.1080/07357907.2025.2557004
Top 78%
0.104DataRank
Top 78%1 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +15 more

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

Clinical Lung Cancer(2022)10.1016/j.cllc.2021.12.010
N/A
0DataRank · unranked
44 citations

Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li +17 more

Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005433
N/A
0DataRank · unranked
28 citations

Yuzhou Chang, No‐Joon Song, Xingjun Wu, Dongjun Chung, Brian Riesenberg +17 more

SUSD2 suppresses CD8+ T cell antitumor immunity by targeting IL-2 receptor signaling

Nature Immunology(2022)10.1038/s41590-022-01326-8
N/A
0DataRank · unranked
21 citations

Weipeng Gong, Anjun Ma, Jianwen Chen, Maria Velegraki, Hong Dong +14 more

TSAFinder: exhaustive tumor-specific antigen detection with RNAseq

Bioinformatics(2022)10.1093/bioinformatics/btac116
N/A
0DataRank · unranked
9 citations

Travis S Johnson, Robert J. Chalkley, Zhi Han, David P. Carbone, Kun Huang +2 more

Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03392-9
N/A
0DataRank · unranked
11 citations

Songzhu Zhao, Gabrielle Lopez, Austin Secor, Parthib Das, Nitya Surya +19 more

Bone modifying agents and skeletal related events in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18593
N/A
0DataRank · unranked
0 citations

Songzhu Zhao, Lai Wei, Abdul Miah, Mingjia Li, Gabrielle Lopez +11 more

Patterns of weight change and overall survival (OS) during first-line pembrolizumab treatment in patients with non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21094
N/A
0DataRank · unranked
0 citations

Songzhu Zhao, Kenneth Chian, Hyunwoo Kwon, Nicholas Jones, Adam Khorasanchi +15 more

IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10

The Journal of Immunology(2024)10.4049/jimmunol.2400056
N/A
0DataRank · unranked
3 citations

Ali Jabbari, Cho-Hao Lin, Akkanapally Venu, Wendy L. Frankel, Sujit Basu +5 more

USP30 inhibition augments mitophagy to prevent T cell exhaustion

Science Advances(2025)10.1126/sciadv.adv6902
N/A
0DataRank · unranked
10 citations

Fengxia Gao, Jianying Li, Jiacheng Jin, Kangxuan Chen, Samhita Chaudhuri +9 more

IL-15: from discovery to FDA approval

Journal of Hematology & Oncology(2025)10.1186/s13045-025-01664-8
N/A
0DataRank · unranked
21 citations

John Wrangle, Kai He, Jonathan Sprent, Mark P. Rubinstein, Zihai Li

Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung Cancer

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.07.002
N/A
0DataRank · unranked
0 citations

Philip Young, Songzhu Zhao, Lai Wei, Sandip H. Patel, Mingjia Li +17 more

Early changes in lymphocyte/monocyte ratio on-treatment as a prognostic marker to predict overall survival in patients with advanced cancer treated with immune checkpoint inhibitors

Research Square(2021)10.21203/rs.3.rs-758097/v1
Top 100%
0DataRank
Top 100%0 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +14 more

Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy

Lung Cancer(2025)10.1016/j.lungcan.2025.108832
N/A
0DataRank · unranked
0 citations

Mingjia Li, Songzhu Zhao, Lai Wei, Evelyn Goodyear, Kevin Ho +16 more